Tatva Chintan Pharma Chem Ltd.
NSE: TATVA | BSE: 543321
₹1,193.50
₹7.60
(0.64%)
As on 17-Jun-2026IST
Market cap
₹2,837 Cr
Revenue (TTM)
₹506 Cr
P/E Ratio
67.5
P/B Ratio
3.6
Div. Yield
0.2 %
Quality Score
5/10
Growth Score
5/10
Valuation Score
5/10
Momentum Score
9/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹42 Cr
-
ROE
0.8 %
-
ROCE
1.2 %
-
Industry P/E
25.61
-
EV/EBITDA
30.5
-
Debt to Equity
0
-
Book Value
₹334.2
-
EPS
₹18
-
Face value
10
-
Shares outstanding
23,392,055
10 Years Aggregate
CFO
₹268.94 Cr
EBITDA
₹490.33 Cr
Net Profit
₹325.76 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tatva Chintan
| -10.5 | -9.3 | 3.7 | 26.2 | -12.5 | -- | -- |
|
BSE Commodities
| 7.3 | -0.6 | 12.4 | 11.3 | 15.6 | 10.5 | 15.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Tatva Chintan
| 55.3 | -44.4 | -25.5 | -19.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tatva Chintan
|
1,193.5 | 2,836.8 | 505.9 | 42.1 | 11.1 | 5.5 | 67.5 | 3.6 |
| 1,816.4 | 9,274.6 | 1,535.9 | 180.0 | 13.9 | 12.3 | 51.5 | 6.1 | |
| 3,502.4 | 15,267.7 | 15,226.8 | 420.1 | 3.4 | 10.7 | 36.3 | 3.9 | |
| 1,550.5 | 19,657.4 | 11,506.0 | 738.8 | 11.0 | 11 | 26.7 | 2.6 | |
| 1,131.0 | 4,881.0 | 2,527.2 | 332.0 | 15.8 | 16.1 | 14.7 | 2.2 | |
| 1,773.0 | 6,323.4 | 5,248.3 | 267.4 | 6.7 | 10.5 | 23.6 | 2.3 | |
| 2,612.5 | 8,369.2 | 15,929.8 | 1,844.4 | 16.6 | 12.4 | 9 | 1.0 | |
| 5,123.5 | 6,947.8 | 1,995.6 | 185.3 | 11.7 | 13.8 | 37.5 | 5.0 | |
| 7,344.0 | 37,937.3 | 3,313.9 | 663.6 | 28.1 | 17.7 | 57.2 | 9.5 | |
| 729.0 | 18,578.1 | 14,584.0 | -1,715.0 | 4.1 | -8 | -- | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Analyst's Diary: Out of season
4 min read•By Hemkesh Khattar
IPO update: Tatva Chintan Pharma Chem
3 min read•By Udhayaprakash
Tatva Chintan Pharma: IPO analysis
6 min read•By Rajan Gulati
About Tatva Chintan
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor... and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals. The company serves various industries, including the automotive, petroleum, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. It also exports its products to various countries, including the United States, Singapore, the United Kingdom, China, Germany, Japan, and South Africa. The company was incorporated in 1996 and is headquartered in Vadodara, India. Read more
-
Incorporated
1996
-
Chairman
Chintan Nitinkumar Shah
-
Managing Director
Chintan Nitinkumar Shah
-
Headquarters
Bharuch, Gujarat
-
Website
Looking for more details about Tatva Chintan Pharma Chem Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsCorporate Action-Board approves Dividend
16-May-2026No News & Announcements are available.
FAQs for Tatva Chintan
What is the current share price of Tatva Chintan Pharma Chem Ltd Today?
The share price of Tatva Chintan Pharma Chem Ltd is ₹1,193.50 (NSE) and ₹1,191.45 (BSE) as of 17-Jun-2026 IST. Tatva Chintan Pharma Chem Ltd has given a return of -12.53% in the last 3 years.
What is the current PB & PE ratio of Tatva Chintan Pharma Chem Ltd?
The P/E ratio of Tatva Chintan Pharma Chem Ltd is 67.46 times as on 17-Jun-2026, a 163 premium to its peers’ median range of 25.61 times.
The P/B ratio of Tatva Chintan Pharma Chem Ltd is 3.63 times as on 17-Jun-2026, a 101 premium to its peers’ median range of 1.81 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
278.00
|
2.15
|
|
2024
|
83.19
|
3.43
|
|
2023
|
81.23
|
7.18
|
|
2022
|
53.35
|
10.81
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Tatva Chintan Pharma Chem Ltd?
The 52-week high and low of Tatva Chintan Pharma Chem Ltd are Rs 1,610.00 and Rs 886.00 as of 17-Jun-2026.
What is the market cap of Tatva Chintan Pharma Chem Ltd?
Tatva Chintan Pharma Chem Ltd has a market capitalisation of ₹ 2,837 Cr as on 17-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Tatva Chintan Pharma Chem Ltd?
Before investing in Tatva Chintan Pharma Chem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.